Ratan Capital Management LP purchased a new position in DENTSPLY SIRONA Inc (NASDAQ:XRAY) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 78,269 shares of the medical instruments supplier’s stock, valued at approximately $5,153,000. DENTSPLY SIRONA makes up about 7.8% of Ratan Capital Management LP’s portfolio, making the stock its 6th biggest holding.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. NuWave Investment Management LLC acquired a new stake in DENTSPLY SIRONA during the fourth quarter valued at approximately $121,000. Massey Quick Simon & CO. LLC acquired a new stake in DENTSPLY SIRONA during the third quarter valued at approximately $124,000. First Interstate Bank acquired a new stake in DENTSPLY SIRONA during the third quarter valued at approximately $164,000. Focused Wealth Management Inc raised its stake in DENTSPLY SIRONA by 79.2% during the fourth quarter. Focused Wealth Management Inc now owns 2,600 shares of the medical instruments supplier’s stock valued at $171,000 after buying an additional 1,149 shares in the last quarter. Finally, Stock Yards Bank & Trust Co. acquired a new stake in DENTSPLY SIRONA during the fourth quarter valued at approximately $203,000. Hedge funds and other institutional investors own 96.80% of the company’s stock.
In related news, Director Eric Brandt sold 6,409 shares of the stock in a transaction that occurred on Monday, January 8th. The stock was sold at an average price of $68.04, for a total value of $436,068.36. Following the completion of the transaction, the director now directly owns 12,073 shares of the company’s stock, valued at approximately $821,446.92. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.99% of the company’s stock.
DENTSPLY SIRONA Inc (NASDAQ XRAY) opened at $58.42 on Tuesday. DENTSPLY SIRONA Inc has a fifty-two week low of $52.53 and a fifty-two week high of $68.98. The stock has a market capitalization of $13,245.81, a P/E ratio of 21.68, a P/E/G ratio of 2.52 and a beta of 1.21. The company has a debt-to-equity ratio of 0.24, a current ratio of 2.12 and a quick ratio of 1.46.
DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Thursday, March 1st. The medical instruments supplier reported $0.82 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.81 by $0.01. DENTSPLY SIRONA had a positive return on equity of 8.35% and a negative net margin of 39.39%. The business had revenue of $1.09 billion during the quarter, compared to analyst estimates of $1.06 billion. During the same period in the prior year, the company posted $0.67 EPS. The business’s revenue for the quarter was up 9.5% compared to the same quarter last year. analysts anticipate that DENTSPLY SIRONA Inc will post 2.74 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 13th. Investors of record on Thursday, March 29th will be issued a $0.0875 dividend. This represents a $0.35 dividend on an annualized basis and a yield of 0.60%. The ex-dividend date of this dividend is Wednesday, March 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -5.09%.
COPYRIGHT VIOLATION NOTICE: “Ratan Capital Management LP Invests $5.15 Million in DENTSPLY SIRONA Inc (XRAY)” was first reported by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this piece of content on another publication, it was illegally stolen and republished in violation of United States & international trademark and copyright legislation. The correct version of this piece of content can be read at https://stocknewstimes.com/2018/03/13/ratan-capital-management-lp-invests-5-15-million-in-dentsply-sirona-inc-xray.html.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.